Tumor necrosis factor-alpha blockade and the risk of vasculitis.

作者信息

Guillevin Loïc, Mouthon Luc

出版信息

J Rheumatol. 2004 Oct;31(10):1885-7.

PMID:15468348

Abstract

摘要

相似文献

Tumor necrosis factor-alpha blockade and the risk of vasculitis.

J Rheumatol. 2004 Oct;31(10):1885-7.

Biologic therapy for rheumatoid arthritis.

N Engl J Med. 2000 Nov 30;343(22):1640-1. doi: 10.1056/NEJM200011303432210.

Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):967-8. doi: 10.1111/j.1468-3083.2008.03074.x. Epub 2009 Jan 29.

TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.

Mayo Clin Proc. 2001 Jun;76(6):573-5.

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Am J Med. 2005 May;118(5):552-6. doi: 10.1016/j.amjmed.2005.01.028.

Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.

J Rheumatol. 2006 May;33(5):831-3.

[TNF antagonists in therapy of rheumatoid arthritis].

Med Monatsschr Pharm. 1999 Nov;22(11):334-9.

Tumor necrosis factor blockers in rheumatoid arthritis.

N Engl J Med. 2000 Mar 16;342(11):810-1. doi: 10.1056/NEJM200003163421110.

Can tumor necrosis factor alpha blockade predispose to severe babesiosis?

Arthritis Rheum. 2007 Feb 15;57(1):179-81. doi: 10.1002/art.22479.

Anti-TNF-alpha therapies: they are all the same (aren't they?).

Rheumatology (Oxford). 2005 Mar;44(3):271-3. doi: 10.1093/rheumatology/keh483. Epub 2004 Nov 23.

引用本文的文献

IgA vasculitis induced by tumor necrosis factor-α antagonists: clinical features, diagnosis and management.

Arch Dermatol Res. 2025 Feb 20;317(1):445. doi: 10.1007/s00403-025-03965-x.

In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors.

Mol Ther. 2025 Feb 5;33(2):670-687. doi: 10.1016/j.ymthe.2024.12.011. Epub 2024 Dec 16.

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases.

Int J Mol Sci. 2023 May 3;24(9):8187. doi: 10.3390/ijms24098187.

Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.

Front Cardiovasc Med. 2021 Mar 29;8:649922. doi: 10.3389/fcvm.2021.649922. eCollection 2021.

A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Clin Drug Investig. 2020 Jun;40(6):541-553. doi: 10.1007/s40261-020-00907-5.

Adalimumab-induced Anti-neutrophilic Cytoplasmic Antibody Vasculitis: A Rare Complication of an Increasingly Common Treatment.

Cureus. 2019 Sep 9;11(9):e5598. doi: 10.7759/cureus.5598.

Cutaneous vasculitis in a patient with ankylosing spondylitis: A case report.

Medicine (Baltimore). 2019 Jan;98(3):e14121. doi: 10.1097/MD.0000000000014121.

Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Eur J Rheumatol. 2017 Jun;4(2):157-160. doi: 10.5152/eurjrheum.2016.039. Epub 2017 Feb 24.

Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis.

World J Gastroenterol. 2015 May 21;21(19):6082-7. doi: 10.3748/wjg.v21.i19.6082.

Adverse reactions to biologic agents and their medical management.

Nat Rev Rheumatol. 2014 Oct;10(10):612-27. doi: 10.1038/nrrheum.2014.123. Epub 2014 Aug 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr
超能文献

Tumor necrosis factor-alpha blockade and the risk of vasculitis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr超能文献

Tumor necrosis factor-alpha blockade and the risk of vasculitis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr
超能文献